Prognostic relevance of preoperative CA 19-9 values in stage III rectal adenocarcinoma: retrospective analysis and clinical implications
Authors:
Open Access
- 1 September 2024
- journal article
- research article
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 21 (2) , 362-367
Abstract
Aim To investigate prognostic significance of preoperative levels of the Carbohydrate anti-gen 19-9 (CA 19-9) in patients with stage III rectal adenocarcinoma who underwent a treatment at the Clinical Centre of the University of Sarajevo.Methods A retrospective cohort study included 84 patients who underwent radical anterior rectal resection due to grade III rectal adenocarcinoma, followed by adjuvant chemotherapy according to the FOLFOX protocol (Oxaliplatin, Leucovorin, 5-Fluorouracil (5-FU)). The patients were divided into two groups according to CA 19-9 values (≥27 U/mL and <27 U/mL, respectively). Results High pre-operative CA 19-9 values predicted an increased probability of postoperative metastases, especially liver, lung and abdominopelvic metastases, as well as three-year disease-free survival (3Y-DFS) and three-year overall survival (3Y-OS). The 3Y-DFS rate for patients with high CA 19-9 was 64.5%, while for those with low CA 19-9 it was 87.2%. The 3Y-OS rate for patients with high CA 19-9 was 89.8%, while for those with low CA 19-9 it was 65.7%. Univariate and multivariate regression analysis confirmed that a high level of CA 19-9 is an independent predictor for DFS and OS shorter than three years.Conclusion Pre-operatively elevated values of CA 19-9 in rectal adenocarcinoma have a significant role in predicting the outcome in patients with stage III rectal adenocarcinoma.Keywords
This publication has 31 references indexed in Scilit:
- Survival Contradiction in Stage II, IIIA, And IIIB Colon Cancer: A Surveillance, Epidemiology, and End Result-Based AnalysisEvidence-Based Complementary and Alternative Medicine, 2022
- Surgery for rectal cancer: Differences in resection rates among hospitals in the NetherlandsEuropean Journal of Surgical Oncology, 2021
- Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2020
- Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population‐based analysisCancer Medicine, 2019
- Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19‐9 is High‐Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic AdenocarcinomaWorld Journal of Surgery, 2018
- Duration of Adjuvant Chemotherapy for Stage III Colon CancerNew England Journal of Medicine, 2018
- Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancerEuropean Journal of Cancer, 2015
- Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection systemCancer, 2014
- Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic CancerClinical Cancer Research, 2014
- Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasisInternational Journal of Colorectal Disease, 2012